Organizational structure

Organization and committees of the DZKJ

Organizational structure

Organization and committees of the DZKJ

Structure in the start-up phase

Central governance structure

During the two-year start-up phase, the DZKJ will not yet be founded as an institution with its own legal form, but will be established as a research network. Selected structures of the planned governance concept ensure an orderly start of the cross-site DZKJ. The following committees and functions are initially planned:

The DZKJ has established a Board of Directors (BOD) for the scientific and operational management of the organisation. It consists of the directors of all seven partner sites and appoints a chair, currently Prof. Jutta Gärtner, and a vice chair, currently Prof. Klaus-Michael Debatin. The BOD is responsible for the implementation of the project and all administrative decisions (e.g. quality, procedures, deadlines, funding management, etc.). The majority principle applies; in the event of a tie, the chairperson has the casting vote.

Prof. Dr. med. Jutta Gärtner

DZKJ Chair and Site Director
University Medical Center Göttingen, Department of Pediatrics and Adolescent Medicine

Prof. Dr. med. Klaus-Michael Debatin

DZKJ Vice Chair and Site Director
Ulm University, Department of Pediatrics and Adolescent Medicine

Prof. Dr. med. Marcus A. Mall 

Site Director
Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine

Prof. Dr. rer. med. Neeltje van den Berg

Site Director
Institute for Community Medicine, Section Epidemiology of Health Care and Community Health 

Prof. Dr. med. Ania C. Muntau

Site Director
University Medical Center Hamburg-Eppendorf, Department of Pediatrics and Adolescent Medicine

Prof. Dr. med. Antje Körner

Site Director
Leipzig University, Faculty of Medicine and University of Leipzig Medical Center, Department of Pediatrics

Prof. Dr. med. Dr. sci. nat. Christoph Klein

Site Director
Dr. von Hauner Children`s Hospital LMU München

Dr. jur. Anja Bratke

Patient representative
Ulm

The SAB consists of 12 external international experts representing the fields of basic research, clinical sciences, population and community health, social sciences and implementation in policy and practice, as well as a patient representative. The SAB appoints a chairperson and a vice chairperson. The members are proposed by the BOD and approved by all participating member organisations. It advises the BOD on scientific strategy and new research programmes. The committee is currently being set up.

M.D., PhD Rebecca Ahrens-Nicklas

Children’s Hospital of Philadelphia, Philadelphia, USA

Dr. rer. nat. Gabriela Bopp

Patientenvertretung

Prof. Jesús Carretero Perez

Universidad Carlos III de Madrid, Leganés, Spain

M.D., M.H.S. Raphaela Goldbach-Mansky

National Institutes of Health, Bethesda, MD, USA

Prof. Dr. med. Georg Holländer

University of Oxford, Oxford, UK
University of Basel and University Children’s Hospital Basel, Basel, Switzerland
ETH Zurich, Basel, Switzerland

Prof. M.D. Eitan Kerem

Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Israel

Prof. Dr. med. Barbara Plecko

Medical University of Graz, Graz, Austria

Prof. Jürgen Schwarze

The University of Edinburgh, Edinburgh, United Kingdom

Prof. Dr. med. Werner Seeger

University Hospital Giessen and Marburg, Max Planck Institute for Heart and Lung Research, German Center for Lung Research

Prof. MA, MD, PhD Henning Tiemeier

University Medical Centre, Rotterdam, the Netherlands
Harvard T.H. Chan School of Public Health, Boston, MA, USA

Prof. Dr. Robert Verheij

Netherlands Institute for Health Services Research (NIVEL), Utrecht, the Netherlands
National Health Care Institute, Diemen, the Netherlands
Tilburg University, Tilburg, the Netherlands

Prof. Dr. Daniel Weghuber

Paracelsus Medical University, Salzburg, Austria

The central managing director, Dr. Doris Boden, MBA, supports all committees of the DZKJ, in particular the Executive Board. She is responsible for financial controlling, public relations, project management, quality and risk management. Ms. Boden is responsible for collaboration with cooperation partners, the publication database, property rights issues and contract management. She establishes project management (PM) as well as quality and risk management (QRM).

Dr. Doris Boden

Chief Operating Officer

Structure in the start-up phase

Local governance at the DZKJ partner sites

All DZKJ partner sites will establish a local governance structure that includes the following elements: a site director, a vice site director, a site chief operating officer (site coordinator), a local steering committee and a local site assembly. The DZKJ partner sites can set up additional structures as required, for example working groups on local priority topics.